Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

Macías J, Marano LE, Tellez F, et al. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71(1):45-51.

Publication Type:

Journal Article

Authors:

Macías, J; Marano, LE; Tellez, F; et, al

Source:

J Hepatol, Volume 71, Issue 1, p.45-51 (2019)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

Export Citation:

RIS Format

Top